Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian Cancer
- 1 March 1999
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 72 (3) , 278-287
- https://doi.org/10.1006/gyno.1998.5145
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Stage IV Ovarian Cancer: Impact of Surgical Debulking1Gynecologic Oncology, 1997
- Prognostic Significance of Residual Disease in Patients with Stage IV Epithelial Ovarian CancerGynecologic Oncology, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Long-Term Survival in Advanced Ovarian Cancer after Cytoreduction and Chemotherapy TreatmentGynecologic Oncology, 1994
- Neoadjuvant Chemotherapy for Advanced Ovarian CancerGynecologic Oncology, 1994
- Neoadjuvant carboplatin and ifosfamide chemotherapy for inoperable FIGO stage III and IV ovarian carcinomaClinical Oncology, 1993
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaGynecologic Oncology, 1992
- Stage III epithelial ovarian cancer: The role of maximal surgical reductionGynecologic Oncology, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958